Vaccines as systemic public health infrastructure: 150M lives saved through collective immunity, equity gaps persist in global access

Indigenous knowledge systems worldwide have long used holistic, community-based approaches to disease prevention, such as the Andean practice of *chakra* biodiversity for immune resilience or the Māori concept of *whanaungatanga* (kinship-based health). These traditions were systematically suppressed during colonial vaccine rollouts, which framed indigenous practices as 'primitive' while positioning Western medicine as the sole legitimate path to health. The WHO’s narrative erases this history, treating vaccines as ahistorical interventions rather than the product of contested knowledge systems.

The 150 million lives saved statistic reflects a century of uneven vaccine deployment, from smallpox eradication campaigns that displaced indigenous healing practices to the apartheid-era sterilization of Black South Africans under the guise of 'public health.' The polio eradication drive in India, celebrated for saving millions, also involved coercive tactics in marginalized communities, mirroring colonial-era medical abuses. Historical records show that vaccine hesitancy often stems from these traumas, yet mainstream narratives frame resistance as irrational rather than a response to systemic betrayal.

Cross-culturally, vaccine acceptance is highest in societies where trust in institutions is built on reciprocal relationships, such as Cuba’s community-based *medicina natural* programs or Kerala’s Kerala Model of public health. In contrast, in settler-colonial states like Canada and Australia, Indigenous communities have lower vaccination rates due to ongoing state violence, including forced sterilizations and residential school abuses. The WHO’s universalist framing ignores how cultural context shapes both vaccine uptake and resistance.

Vaccines are among the most rigorously tested medical interventions, with efficacy rates exceeding 90% for diseases like measles and polio when administered equitably. However, the scientific narrative often obscures how corporate control over vaccine patents (e.g., Pfizer/BioNTech’s mRNA monopoly) limits global supply and inflates costs, particularly in low-income countries. The WHO’s figure of 150 million lives saved relies on modeling that assumes perfect distribution, which is rarely achieved due to structural barriers like cold chain logistics and healthcare deserts.

Artistic and spiritual traditions have long visualized immunity as a collective endeavor, from the African proverb 'If you want to go fast, go alone. If you want to go far, go together' to Buddhist concepts of *karuṇā* (compassionate action) in public health. Indigenous artists like the Māori *tohunga* (healers) have used carvings and chants to encode immunity knowledge, while global protest art during COVID-19 highlighted the spiritual dimensions of vaccine equity. These perspectives challenge the biomedical reductionism of mainstream narratives.

Future modeling suggests that vaccine equity could save an additional 50 million lives by 2040 if patent waivers and technology transfers are implemented, yet current trajectories favor high-income nations stockpiling boosters. Scenario planning must account for climate-induced disease spread (e.g., dengue in new regions) and the erosion of herd immunity due to corporate-driven booster mandates that prioritize profit over public health. The WHO’s 150 million lives saved metric may underestimate future losses if structural inequities persist.

Marginalized communities—Black Americans, Roma populations, Indigenous groups, and refugees—experience vaccine hesitancy not as ignorance but as a rational response to histories of medical abuse, such as the Tuskegee experiments or Canada’s forced sterilizations of Indigenous women. Their perspectives are systematically excluded from global health policy, despite evidence that community-led vaccination programs (e.g., Brazil’s *Programa Saúde da Família*) achieve higher uptake. The WHO’s narrative frames these voices as 'challenges' to be overcome rather than as critical stakeholders in health governance.